Combined Spinal-epidural Anesthesia for Cesarean Section Without Prophylactical Prehydration and Vasopressors
Summary
Hypotension is a common complication in pregnant women after spinal anesthesia and related with the dose of local anesthetic. Injecting small dose local anesthetic into subarachnoid space can decrease the incidence of hypotension, but increase the risk of incomplete analgesia and muscle relaxation. The investigators hypothesize there is an optimal dose of bupivacaine and ropivacaine for subarachnoid injection in pregnant women, which can cause enough anesthesia and obviously decrease the incidence of hypotension without prophylactical prehydration and vasopressors. To verify this hypothesis, full-term pregnant women who were scheduled for elective cesarean section were recruited.Combined spinal-epidural anesthesia was performed for pregnant women after written informed consents. The dose of bupivacaine or ropivacaine is small and depends on height of pregnant women. The blood pressure, heart rate, respiratory rate, SpO2 and fetal heart rate were recorded and the blood flow volume of uterine artery was monitored The sensory and motor block were evaluated. After delivery, umbilical blood samples were taken for blood gas analysis. APGAR scores and neurological behavior of infant were evaluated and recorded. In the intraoperative period, side-effects and requirement for sedation, epidural injection or general anesthesia were noted. The quality of anaesthesia (judged by the anaesthetist), the quality of muscle relaxation (judged by the surgeon) and the degree of intraoperative comfort (judged by the patient) were recorded as excellent, good, fair or poor.
Timeline
- Start
- 2018-05-01
- Primary completion
- 2021-11-30
- Completion
- 2021-11-30
Outcome
Met primary endpoint
paper The height-based dosing algorithm of bupivacaine decreased the incidence of hypotension (p = 0.004), PMID 35755061 ↗
Publications
- Huang J, Wen G, Huang Q, Huang B. Anesthesia characteristic of an algorithm of bupivacaine dose based on height in caesarean section under spinal anesthesia: a retrospective cohort study. BMC Anesthesiol. 2023 May 2;23(1):146. doi: 10.1186/s12871-023-02113-0.
- Huang Q, Wen G, Hai C, Zheng Z, Li Y, Huang Z, Huang B. A Height-Based Dosing Algorithm of Bupivacaine in Spinal Anesthesia for Decreasing Maternal Hypotension in Cesarean Section Without Prophylactic Fluid Preloading and Vasopressors: A Randomized-Controlled Non-Inferiority Trial. Front Med (Lausanne). 2022 Jun 10;9:858115. doi: 10.3389/fmed.2022.858115. eCollection 2022.
- Huang B, Huang Q, Hai C, Zheng Z, Li Y, Zhang Z. Height-based dosing algorithm of bupivacaine in spinal anaesthesia for decreasing maternal hypotension in caesarean section without prophylactic fluid preloading and vasopressors: study protocol for a randomised controlled non-inferiority trial. BMJ Open. 2019 May 16;9(5):e024912. doi: 10.1136/bmjopen-2018-024912.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 1.15 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.2 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.25 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.3 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.35 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.4 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.45 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.5 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.55 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.6 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.65 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 1.7 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 1.475 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 1.55 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 1.625 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 1.7 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 1.775 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 1.85 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 1.925 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 2 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 2.075 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 2.15 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 2.225 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 2.3 ml | Other |
Indications
No indication recorded.